Authors:
Droin, N
Rebe, C
Bichat, F
Hammann, A
Bertrand, R
Solary, E
Citation: N. Droin et al., Modulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization, ONCOGENE, 20(2), 2001, pp. 260-269
Authors:
Solary, E
Droin, N
Bettaieb, A
Corcos, L
Dimanche-Boitrel, MT
Garrido, C
Citation: E. Solary et al., Positive and negative regulation of apoptotic pathways by cytotoxic agentsin hematological malignancies, LEUKEMIA, 14(10), 2000, pp. 1833-1849
Authors:
Droin, N
Beauchemin, M
Solary, E
Bertrand, R
Citation: N. Droin et al., Identification of a caspase-2 isoform that behaves as an endogenous inhibitor of the caspase cascade, CANCER RES, 60(24), 2000, pp. 7039-7047
Authors:
Sordet, O
Bettaieb, A
Bruey, JM
Eymin, B
Droin, N
Ivarsson, M
Garrido, C
Solary, E
Citation: O. Sordet et al., Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells, CELL DEAT D, 6(4), 1999, pp. 351-361
Authors:
Eymin, B
Haugg, M
Droin, N
Sordet, O
Dimanche-Boitrel, MT
Solary, E
Citation: B. Eymin et al., p27(Kip1) induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells, ONCOGENE, 18(7), 1999, pp. 1411-1418
Authors:
Eymin, B
Sordet, O
Droin, N
Munsch, B
Haugg, M
Van de Craen, M
Vandenabeele, P
Solary, E
Citation: B. Eymin et al., Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27(Kip1) mediates its anti-apoptotic activity, ONCOGENE, 18(34), 1999, pp. 4839-4847
Authors:
Favre, N
Bonnotte, B
Droin, N
Fromentin, A
Solary, E
Martin, F
Citation: N. Favre et al., Fas(CD95) ligand expression by tumor cell variants can be unrelated to their capacity to induce tolerance or immune rejection, INT J CANC, 82(3), 1999, pp. 359-367